Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Restrata Wound Matrix

K-Number: K170300 · 2017-04-26

Decision Date2017-04-26
Product CodeQSZ
DecisionSubstantially Equivalent

Device Summary

Restrata Wound Matrix is a medical device manufactured by Acera Surgical, Inc.. It received FDA 510(k) clearance on 2017-04-26 under approval number K170300. The device is classified under product code QSZ. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Restrata Wound Matrix?

Restrata Wound Matrix is a medical device that received FDA 510(k) clearance on 2017-04-26. It is manufactured by Acera Surgical, Inc.. The 510(k) number is K170300.

When was Restrata Wound Matrix approved by the FDA?

Restrata Wound Matrix received FDA 510(k) clearance on 2017-04-26, under approval number K170300.

What company makes Restrata Wound Matrix?

Restrata Wound Matrix is manufactured by Acera Surgical, Inc..

What is the FDA product code for Restrata Wound Matrix?

The FDA product code for Restrata Wound Matrix is QSZ.

Related Clinical Trials

Other Devices by Acera Surgical, Inc.

View all 7 devices →

Related Devices (Code: QSZ)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.